Cohen-Adad J, El Mendili MM, Lehricy S, Pradat PF, Blancho S, Rossignol S, et al
Research suggests that tirzepatide causes a 40% reduction in visceral fat mass and a 7-inch reduction in waist circumference after 72 weeks
Risk of Allergic Reactions: Unfortunately, anyone can develop an allergy to any medication at any time, regardless of how long he or she has been using it
Tirzepatide's dual GIP/GLP-1 mechanism makes it distinct from pure GLP-1 agonists like semaglutide or liraglutide
Alternative strategies to harness the glucose-lowering action of GLP-1 Besides the production of formulations of GLP-1 receptor agonists with longer durations of action, other strategies for harnessing the glucose-lowering actions of GLP-1 have been developed
Chromium contributes to normal macronutrient metabolism and the maintenance of normal blood glucose levels